Skip to main content

Table 1 Laboratory findings of the patient before and after treatment with methylprednisolone

From: Coronavirus disease 2019 (COVID-19) in a pregnant women with treatment resistance thrombocytopenic purpura with and suspicion to HELLP syndrome: a case report

Variable

Before MP

HD 1 *

HD 9 ⁑

HD 13 ⁑*

HD 17 ⁑⁑

White-cell count (per mL)

9040

10,500

9290

8200

9000

Absolute lymphocyte count (per mL)

361 (4%)

1575 (15%)

650 (7%)

820 (10%)

1440 (16%)

Absolute neutrophil count, (per mL)

8226 (91%)

8505 (81%)

8268 (89%)

7134 (87%)

7470 (83%)

Platelet count× 103 (per mL)

6➔62

56

6➔┼┼105

75

71

Hemoglobin (gr/dL)

11.2

11.6

10.4

9.3

11.5

Hematocrit (%)

34

35

31.3

29.3

36.4

Erythrocyte sedimentation rate (mm/h)

57

N/A

N/A

N/A

N/A

C-reactive protein (mg/L)

N/A

30

N/A

N/A

N/A

Creatinine (mg/dL)

0.72

0.64

0.64

0.64

0.4

Blood urea nitrogen (mg/dL)

9

16

14

26

12

Aspartate aminotransferase (U/L)

53

N/A

346

1173

133

Alanine aminotransferase (U/L)

65

N/A

477

2030

800

Lactate dehydrogenase (U/L)

430

N/A

971

1301

546

  1. MP Methylprednisolone pulse, HD Hospital day, N/A Not applicable
  2. ┼: After 1 unit of single donor platelet transfusion. ┼┼: After 10 units of platelet transfusion. *: The patient was transferred to the COVID-19 ward. ⁑: Cesarean section performed and MP started. ⁑*: After the last pulse of MP. ⁑⁑: Four days after last MP pulse. →: following transfusion. During the hospitalization, other laboratory parameters such as levels of total bilirubin, albumin, fibrinogen, prothrombin time (PT), partial thromboplastin time (PTT), Na, and K were in the normal range